ARCH Venture Management as of June 30, 2024
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beam Therapeutics (BEAM) | 47.9 | $128M | 5.4M | 23.43 | |
| Rapport Therapeutics (RAPP) | 32.6 | $87M | 3.7M | 23.26 | |
| Erasca (ERAS) | 9.8 | $26M | 11M | 2.36 | |
| Verve Therapeutics (VERV) | 3.7 | $9.8M | 2.0M | 4.88 | |
| Gossamer Bio (GOSS) | 2.7 | $7.3M | 8.1M | 0.90 | |
| Q32 Bio (QTTB) | 2.2 | $5.8M | 321k | 17.95 | |
| Unity Biotechnology Com New (UBX) | 0.5 | $1.4M | 1.0M | 1.35 | |
| Singular Genomics Systems Com New (OMIC) | 0.4 | $1.1M | 127k | 8.45 | |
| Cero Therapeutics Holdings Class A Com (CERO) | 0.2 | $432k | 1.4M | 0.30 |
